Hercules Capital Faces Class Action Lawsuit Over Alleged Investor Deception

NEW YORK — A securities class action lawsuit has been filed against Hercules Capital, Inc. (NYSE: HTGC), a prominent business development company, alleging that it made false and misleading statements to investors regarding its due diligence processes and portfolio valuations. The lawsuit covers investors who purchased Hercules securities between May 1, 2025, and February 27, 2026, and sets a deadline of May 19, 2026, for an investor to be appointed as lead plaintiff. The case highlights the critical importance of transparency and rigorous vetting in the capital markets. For both investors and the companies seeking funding, the integrity of a lender's internal processes is the bedrock of a successful financial partnership. The complaint, announced by multiple law firms including Bronstein, Gewirtz & Grossman LLC and The Schall Law Firm, centers on accusations that Hercules Capital violated federal securities laws. Specifically, the lawsuit alleges the company overstated the rigor of its due diligence for both its deal sourcing and its ongoing portfolio valuation. It further claims that Hercules misclassified certain portfolio investments, which ultimately led to the company misrepresenting and overstating the value of its portfolio and its overall Net Asset Value (NAV). Hercules Capital operates as a business development company (BDC), providing financing solutions and loans primarily to high-growth, venture capital-backed companies in the technology and life sciences sectors. For many emerging businesses, BDCs are a crucial source of capital. The lawsuit argues that during the class period, Hercules’ positive public statements about its business operations and prospects were materially misleading because they were based on these allegedly flawed internal processes. According to the complaint filed by separate counsel on March 20, 2026, the alleged misrepresentations created an artificially inflated view of the company's financial health and the quality of its loan book. When the market eventually learned the truth about Hercules’ practices, the lawsuit contends, investors suffered significant financial damages. In our experience, a situation like this serves as a potent reminder for small and mid-sized businesses about the importance of who they choose as a capital partner. The due diligence process is a two-way street. While the funder vets the company, the company must also vet the funder’s reputation and processes. Allegations of inflated valuations or lax underwriting at a lender can create significant instability for the portfolio companies that depend on that capital. This is why C&S Finance Group LLC emphasizes a meticulous approach to capital raising and investor strategy, ensuring our clients partner with reputable sources and present their own financials with unimpeachable clarity. For guidance on navigating these complex relationships, business leaders can visit us at csfinancegroup.com. Several national shareholder rights litigation firms, including Hagens Berman and Kirby McInerney LLP, are now urging investors who incurred substantial losses on their Hercules Capital investments to come forward. The legal actions seek to recover damages on behalf of all individuals and entities that acquired the company's securities during the specified period. The law firm Hagens Berman noted that its investigation is focused on the propriety of Hercules' disclosures and is looking into allegations, reportedly originating from a group called Hunterbrook, about the company's sourcing, underwriting, and valuation methods. The legal basis for the suit rests on alleged violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, which prohibit deceptive and manipulative practices in connection with the sale of securities. The lead plaintiff, who acts on behalf of all other class members in directing the litigation, must be appointed by the court. Any member of the purported class may move the court to serve as lead plaintiff through counsel of their choice. For the broader market of venture-backed companies, this lawsuit casts a spotlight on the practices of specialty lenders. BDCs play a vital role in funding innovation, but their business model relies heavily on investor confidence in their ability to accurately assess risk and value complex, often pre-profitability, enterprises. Any erosion of that confidence can have ripple effects, potentially tightening the availability of capital for the very growth-stage companies Hercules aims to support. Ultimately, the core of this legal challenge is about trust and transparency. When a financial institution's public statements about its disciplined investment process are called into question, it affects everyone from the public shareholder to the private portfolio company. It underscores that defensible valuations and clear, honest communication are not just best practices but essential components of a stable financial ecosystem. Moving forward, the legal proceedings will continue with the court's selection of a lead plaintiff after the May 19 deadline. Hercules Capital is expected to formally respond to the allegations, and the case will be closely monitored by investors, regulators, and the venture debt community for its potential impact on industry standards and practices.